Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Velan Bhoopalan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cytotherapy|June 18, 2023
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysisAlexandre G Troullioud Lucas, Caroline A Lindemans, Senthil Velan Bhoopalan, et al.
Cytotherapy|September 25, 2024
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committeeJoseph H Oved, Athena Russell, Amy DeZern, et al.
JCI Insight|November 22, 2022
An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activitySenthil Velan Bhoopalan, Jonathan S Yen, Thiyagaraj Mayuranathan, et al.
Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.
Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.
Cytotherapy|March 14, 2024
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering CommitteeTami D John, Gabriela Maron, Allistair Abraham, et al.
Blood|January 26, 2026
GATA1 N-terminus coordinates metabolic reprogramming in erythropoiesisTe Ling, Lavanya Bezavada, Rashid Mehmood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
Preclinical development of lentiviral vector gene therapy for Diamond-Blackfan anemia syndromeSenthil Velan Bhoopalan, Thiyagaraj Mayuranathan, Nana Liu, et al.
Nature Biomedical Engineering|April 17, 2023
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in miceKelcee A Everette, Gregory A Newby, Rachel M Levine, et al.
Blood|December 3, 2025
Utility of Peripheral Blood Testing for Detection and Surveillance of Clonal Hematopoiesis in Predisposed Individuals (CH-IPI)Enrico Attardi, Nathan Gray, Sara Lewis, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cytotherapy|June 18, 2023
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysisAlexandre G Troullioud Lucas, Caroline A Lindemans, Senthil Velan Bhoopalan, et al.
Cytotherapy|September 25, 2024
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committeeJoseph H Oved, Athena Russell, Amy DeZern, et al.
JCI Insight|November 22, 2022
An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activitySenthil Velan Bhoopalan, Jonathan S Yen, Thiyagaraj Mayuranathan, et al.
Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.
Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.
Cytotherapy|March 14, 2024
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering CommitteeTami D John, Gabriela Maron, Allistair Abraham, et al.
Blood|January 26, 2026
GATA1 N-terminus coordinates metabolic reprogramming in erythropoiesisTe Ling, Lavanya Bezavada, Rashid Mehmood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
Preclinical development of lentiviral vector gene therapy for Diamond-Blackfan anemia syndromeSenthil Velan Bhoopalan, Thiyagaraj Mayuranathan, Nana Liu, et al.
Nature Biomedical Engineering|April 17, 2023
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in miceKelcee A Everette, Gregory A Newby, Rachel M Levine, et al.
Blood|December 3, 2025
Utility of Peripheral Blood Testing for Detection and Surveillance of Clonal Hematopoiesis in Predisposed Individuals (CH-IPI)Enrico Attardi, Nathan Gray, Sara Lewis, et al.
Pageof 3